ArticleACS omega2023
Pd-Coordinated Salinidol-Modified Mixed MOF: An Excellent Active Center for Efficient Nitroarenes Reduction and Selective Oxidation of Alcohols.
Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 14 citations in OpenAlex.
- 2-Chloro-5-(trifluoromethyl)aniline-Derived Schiff Base Palladium(II) Complexes: From Molecular Design to Acute Toxicity Assessment.ChemistryOpen · 2026Article
- Pd nanoparticles decorated on a porous Co(BDC-NHNanoscale advances · 2023Article
- Facile synthesis of a new covalent organic nanosheet (CON-KEY1) based on polyamide links as an effective heterogeneous catalyst in C-C cross coupling reactions.RSC advances · 2023Article
- Synthesis of a Au/Au NPs-PPy/l-CYs/ZIF-8 nanocomposite electrode for voltammetric determination of insulin in human blood.RSC advances · 2023Article
- A sustainable protocol for selective alcohols oxidation using a novel iron-based metal organic framework (MOF-BASU1).RSC advances · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Selective oxidation of active and inactive alcohol substrates and reduction of nitroarenes is a highly versatile conversion that remains a challenge in controlling functionality and adjustments in metal-organic frameworks (MOFs). On the other hand, it offers an attractive opportunity to expand their applications in designing the next generation of catalysts with improved performance. Herein, a novel mixed MOF consisting of supported 2-hydroxybenzamide (mixed MOF-salinidol) has been fabricated by post-synthetic modifications of mixed MOF. Subsequently, the prepared nanocomposites were modified to impart catalytic sites using palladium chloride ions mixed with MOF-salinidol/Pd (II). After successfully designing and structurally characterizing nanocomposites, we evaluated their activity in oxidizing primary and secondary alcohols using aerobic conditions with molecular oxygen and an air atmosphere. In addition, the stability of (mixed MOF-salinidol/Pd (II)) catalysts under catalytic conditions was also demonstrated by comparing the Fourier-transform infrared spectrum, scanning electron microscopy image, and ICP-OES method before and after catalysis. Based on the results, the active surface area of the synthesized nanocatalyst is large, which highlights its unique synergistic effect between post-synthetic modified MOF and Pd, and furthermore, the availability of catalytic sites from Pd, as demonstrated by outstanding catalytic activity.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.